drugset / Trial / NCT00170664
Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer
NaSingle-groupOpen-labelTreatment
Summary
The combination of paclitaxel and carboplatin in a three weeks schedule has emerged as the current standard approach for the adjuvant treatment of ovarian cancer. Based on a phase I study now a multi-center phase II-trial was conducted.
Timeline
- Start
- 1999-01
- Primary completion
- 2003-03
- Completion
- 2004-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Paclitaxel | Small molecule | — | — |